369 related articles for article (PubMed ID: 21364117)
1. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa.
Kanj SS; Kanafani ZA
Mayo Clin Proc; 2011 Mar; 86(3):250-9. PubMed ID: 21364117
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the
Viala B; Zaidi FZ; Bastide M; Dumont Y; Le Moing V; Jean-Pierre H; Godreuil S
Microb Drug Resist; 2019 Nov; 25(9):1325-1329. PubMed ID: 31225764
[No Abstract] [Full Text] [Related]
3. [Approach to directed therapy after knowledge of the isolate: carbapenemase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii].
Martínez JA
Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():31-4. PubMed ID: 27608310
[TBL] [Abstract][Full Text] [Related]
4. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
[TBL] [Abstract][Full Text] [Related]
5. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073
[TBL] [Abstract][Full Text] [Related]
6. The ideal patient profile for new beta-lactam/beta-lactamase inhibitors.
Montravers P; Bassetti M
Curr Opin Infect Dis; 2018 Dec; 31(6):587-593. PubMed ID: 30299359
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae.
Santevecchi BA; Smith TT; MacVane SH
Int J Antimicrob Agents; 2018 Apr; 51(4):629-635. PubMed ID: 29408227
[TBL] [Abstract][Full Text] [Related]
8. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
9. Management of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: current evidence and future prospects.
Sheu CC; Lin SY; Chang YT; Lee CY; Chen YH; Hsueh PR
Expert Rev Anti Infect Ther; 2018 Mar; 16(3):205-218. PubMed ID: 29402125
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.
Satlin MJ; Walsh TJ
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazobactam Susceptibility.
Shortridge D; Pfaller MA; Castanheira M; Flamm RK
Microb Drug Resist; 2018 Jun; 24(5):563-577. PubMed ID: 29039729
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
Rodríguez-Baño J; Gutiérrez-Gutiérrez B; Machuca I; Pascual A
Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29444952
[TBL] [Abstract][Full Text] [Related]
13. New guidelines to treat bacterial infections.
Mushtaq A; Kazi F
Lancet Infect Dis; 2020 Nov; 20(11):1239. PubMed ID: 33098778
[No Abstract] [Full Text] [Related]
14. Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review.
Reddy P; Chadaga S; Noskin GA
J Hosp Med; 2009 Jul; 4(6):E8-15. PubMed ID: 19670375
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
[TBL] [Abstract][Full Text] [Related]
16. Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers.
Crandon JL; Nicolau DP
Antimicrob Agents Chemother; 2013 Jul; 57(7):3299-306. PubMed ID: 23650162
[TBL] [Abstract][Full Text] [Related]
17. Treatment of multidrug-resistant Gram-negative infections in children.
Hsu AJ; Tamma PD
Clin Infect Dis; 2014 May; 58(10):1439-48. PubMed ID: 24501388
[TBL] [Abstract][Full Text] [Related]
18. The effect of gut microbiota and probiotic organisms on the properties of extended spectrum beta-lactamase producing and carbapenem resistant Enterobacteriaceae including growth, beta-lactamase activity and gene transmissibility.
Kunishima H; Ishibashi N; Wada K; Oka K; Takahashi M; Yamasaki Y; Aoyagi T; Takemura H; Kitagawa M; Kaku M
J Infect Chemother; 2019 Nov; 25(11):894-900. PubMed ID: 31178280
[TBL] [Abstract][Full Text] [Related]
19. Rapid Blue-Carba test: reduction in the detection time of carbapenemases performed from a 4-hour bacterial lawn.
Nastro M; Ayora M; García S; Vay C; Famiglietti Á; Rodriguez CH
J Chemother; 2017 Jun; 29(3):150-153. PubMed ID: 27347714
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
Falagas ME; Karageorgopoulos DE; Nordmann P
Future Microbiol; 2011 Jun; 6(6):653-66. PubMed ID: 21707312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
